Avidity Biosciences, Inc. (RNA)
BREAKING: Novartis acquires Avidity Biosciences for $12B, boosting its rare disease pipeline with RNA therapies. This strategic move highlights the value of Avidity's AOC platform.
About Avidity Biosciences, Inc.
Avidity Biosciences, Inc. is a biopharmaceutical company focused on developing RNA-based therapeutics.
Avidity Biosciences, Inc. uses the ticker $RNA for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Avidity Biosciences, Inc. (RNA) social dominance is up 50% from the previous week.
- Avidity Biosciences, Inc. (RNA) sentiment is up 66% from the previous month.
Price: $72.90
Price 24-Hour Time-Series Raw Data
The stock price is nearing its 52-week high, driven by the news of the Novartis acquisition which offers a significant premium, leading to increased trading volume and positive sentiment.
24-Hour: -0.04% 7-Day: 0.02% 30-Day: 0.5%
1-Year High: $72.90 on 2026-02-03
1-Year Low: $24.10 on 2025-04-08
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Avidity Biosciences, Inc. (RNA) is currently AltRank #1,502 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] +400
[--] Month: [-----] +1,370
[--] Months: [-----] +1,311
[--] Year: [-----] +1,118
1-Year High: [-----] on 2026-02-15
1-Year Low: [--] on 2025-08-10
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-09-24
1-Year Low: [--] on 2025-04-13
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Week: [------] -43%
[--] Month: [-------] -39%
[--] Months: [---------] +77%
[--] Year: [---------] +28%
1-Year High: [-------] on 2025-10-26
1-Year Low: [---] on 2026-02-16
Engagements by network (24h): News: [--] X: [---] TikTok: [--] Reddit: [--] YouTube: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [---] -5.40%
[--] Month: [---] -5.10%
[--] Months: [-----] +66%
[--] Year: [-----] +23%
1-Year High: [-----] on 2025-10-27
1-Year Low: [--] on 2026-02-16
Mentions by network (24h): News: [--] X: [--] TikTok: [--] Reddit: [--] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Avidity Biosciences, Inc. (RNA) in the last [--] hours which is down 23% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -11%
[--] Month: [---] -5.10%
[--] Months: [-----] +46%
[--] Year: [-----] +89%
1-Year High: [---] on 2025-10-28
1-Year Low: [--] on 2025-05-03
The most influential creators that mention Avidity Biosciences, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @HedgeFundTips | [--] | [------] | [--] | [--] |
Sentiment: 67%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 67%
Daily Average: 80%
[--] Week: 100% +33%
[--] Month: 83% +33%
[--] Months: 83% -6%
[--] Year: 83% -5%
1-Year High: 100% on 2025-02-21
1-Year Low: 32% on 2025-12-06
Most Supportive Themes:
- Novartis Acquisition: (80%) Novartis is acquiring Avidity Biosciences for $12 billion, significantly bolstering its rare disease pipeline with Avidity's RNA-based therapies.
- RNA Therapeutics Pipeline: (15%) Avidity's proprietary Antibody Oligonucleotide Conjugates (AOCs) platform and late-stage RNA therapies are key assets driving the acquisition.
Most Critical Themes:
- Clinical Holds and Discontinuations: (5%) Concerns exist regarding potential clinical holds and Discontinuations in related RNA therapies, which could impact future developments.
Social Dominance: 0.00177%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00177%
Daily Average: 0.016%
[--] Week: 0.0054% +0.0018%
[--] Month: 0.0029% -0.0038%
[--] Months: 0.0029% -0.013%
[--] Year: 0.0029% -0.013%
1-Year High: 0.132% on 2025-10-27
1-Year Low: 0.0025% on 2026-02-15
Market Dominance: 0.013%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.013%
Daily Average: 0%
1-Year High: 0.133% on 2025-03-31
1-Year Low: 0.00451% on 2025-06-30
Market Cap: $11,256,875,330
Market Cap 24-Hour Time-Series Raw Data
Current Value: $11,256,875,330
Daily Average: $6,549,627,201
[--] Week: $11,230,613,922 -0.27%
[--] Month: $11,256,875,330 +3%
[--] Months: $11,256,875,330 +97%
[--] Year: $11,256,875,330 +192%
1-Year High: $11,266,144,062 on 2026-02-03
1-Year Low: $2,894,712,208 on 2025-04-08
Top Avidity Biosciences, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"LT position into [----] Part [--] # [--] Portfolio Pick Buyouts $RNA $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP $ITCI $KVUE Tech positions in order- $AMZN $TSLA $SOFI $COIN $GOOG $NVDA $AMD $RBRK $META $NFLX $UBER $MSFT $AVGO $ZS $MELI $IREN $NBIS Top Biotech positions: $VKTX $CYTK $BBIO $TMDX $MDGL $HROW $SLNO $IMNM $GPCR $OCUL $CRVS https://twitter.com/i/web/status/2002067407834374356 https://twitter.com/i/web/status/2002067407834374356"
X Link @Pharmdca 2025-12-19T17:24Z 108.6K followers, 56.4K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing